These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 20649989)

  • 21. Intestinal Dendritic Cells Are Altered in Number, Maturity and Chemotactic Ability in Fulminant Hepatic Failure.
    Liu M; Wang P; Zhao M; Liu DY
    PLoS One; 2016; 11(11):e0166165. PubMed ID: 27832135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemokine 25-induced signaling suppresses colon cancer invasion and metastasis.
    Chen HJ; Edwards R; Tucci S; Bu P; Milsom J; Lee S; Edelmann W; Gümüs ZH; Shen X; Lipkin S
    J Clin Invest; 2012 Sep; 122(9):3184-96. PubMed ID: 22863617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CCL25 chemokine-guided stem cell attraction: an assessment of possible benefits and risks.
    Spinnen J; Ringe J; Sittinger M
    Regen Med; 2018 Oct; 13(7):833-844. PubMed ID: 30284497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical significance and biological function of lncRNA SOCAR in serous ovarian carcinoma.
    Guo Q; Wang L; Zhu L; Lu X; Song Y; Sun J; Wu Z; Shi J; Wang Z; Zhou X
    Gene; 2019 Sep; 713():143969. PubMed ID: 31299360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesenchymal stem cells and their chondrogenic differentiated and dedifferentiated progeny express chemokine receptor CCR9 and chemotactically migrate toward CCL25 or serum.
    Ullah M; Eucker J; Sittinger M; Ringe J
    Stem Cell Res Ther; 2013 Aug; 4(4):99. PubMed ID: 23958031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCR9 mediates PI3K/AKT-dependent antiapoptotic signals in prostate cancer cells and inhibition of CCR9-CCL25 interaction enhances the cytotoxic effects of etoposide.
    Sharma PK; Singh R; Novakovic KR; Eaton JW; Grizzle WE; Singh S
    Int J Cancer; 2010 Nov; 127(9):2020-30. PubMed ID: 20127861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasis.
    Gupta P; Sharma PK; Mir H; Singh R; Singh N; Kloecker GH; Lillard JW; Singh S
    Oncotarget; 2014 Oct; 5(20):10170-9. PubMed ID: 25296976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CCL25/CCR9 interactions are not essential for colitis development but are required for innate immune cell protection from chronic experimental murine colitis.
    Wurbel MA; Le Bras S; Ibourk M; Pardo M; McIntire MG; Coco D; Geha RS; Fiebiger E; Snapper SB
    Inflamm Bowel Dis; 2014 Jul; 20(7):1165-76. PubMed ID: 24874458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of metastasis-associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells.
    Zhang R; Shi H; Chen Z; Wu Q; Ren F; Huang H
    J Exp Clin Cancer Res; 2011 Sep; 30(1):83. PubMed ID: 21923915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The murine DCs transfected with DNA-plasmid encoding CCR9 demonstrate the increased migration to CCL25 and thymic cells in vitro and to the thymus in vivo.
    Tereshchenko V; Bulygin A; Zavodskii R; Maksyutov A; Kurilin V; Fisher M; Semenyuk N; Aladev S; Sennikov S
    Cytokine; 2021 Jun; 142():155473. PubMed ID: 33647585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of CCR9 expression and CCL25/thymus-expressed chemokine responsiveness during T cell development: CD3(high)CD69+ thymocytes and gammadeltaTCR+ thymocytes preferentially respond to CCL25.
    Uehara S; Song K; Farber JM; Love PE
    J Immunol; 2002 Jan; 168(1):134-42. PubMed ID: 11751956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemokine (C-C motif) ligand 25 expressed by trophoblast cells and leukocytes bearing its receptor Ccr9: An alliance during embryo implantation?
    Weingrill RB; Hoshida MS; Martinhago CD; Correa-Silva S; Cardoso E; Palmeira P; Marinho CRF; Bevilacqua E
    Am J Reprod Immunol; 2018 Jan; 79(1):. PubMed ID: 29154408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis.
    Morikawa R; Nakamoto N; Amiya T; Chu PS; Koda Y; Teratani T; Suzuki T; Kurebayashi Y; Ueno A; Taniki N; Miyamoto K; Yamaguchi A; Shiba S; Katayama T; Yoshida K; Takada Y; Ishihara R; Ebinuma H; Sakamoto M; Kanai T
    J Hepatol; 2021 Mar; 74(3):511-521. PubMed ID: 33038434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of the CCL25-CCR9 axis in beta-cell function: potential for therapeutic intervention in type 2 diabetes.
    Atanes P; Lee V; Huang GC; Persaud SJ
    Metabolism; 2020 Dec; 113():154394. PubMed ID: 33058852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of TECK/CCL25 and MEC/CCL28 chemokines and their respective receptors CCR9 and CCR10 in porcine mucosal tissues.
    Meurens F; Berri M; Whale J; Dybvig T; Strom S; Thompson D; Brownlie R; Townsend HG; Salmon H; Gerdts V
    Vet Immunol Immunopathol; 2006 Oct; 113(3-4):313-27. PubMed ID: 16839611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin-converting enzyme inhibition down-regulates the pro-atherogenic chemokine receptor 9 (CCR9)-chemokine ligand 25 (CCL25) axis.
    Abd Alla J; Langer A; Elzahwy SS; Arman-Kalcek G; Streichert T; Quitterer U
    J Biol Chem; 2010 Jul; 285(30):23496-505. PubMed ID: 20504763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia-inducible factor-1α induces CX3CR1 expression and promotes the epithelial to mesenchymal transition (EMT) in ovarian cancer cells.
    Singh SK; Mishra MK; Singh R
    J Ovarian Res; 2019 May; 12(1):42. PubMed ID: 31077234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion.
    Ellerbroek SM; Hudson LG; Stack MS
    Int J Cancer; 1998 Oct; 78(3):331-7. PubMed ID: 9766568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Higher CXCL16 exodomain is associated with aggressive ovarian cancer and promotes the disease by CXCR6 activation and MMP modulation.
    Mir H; Kaur G; Kapur N; Bae S; Lillard JW; Singh S
    Sci Rep; 2019 Feb; 9(1):2527. PubMed ID: 30792527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of CCR9 beta-chemokine receptor is modulated in thymocyte differentiation and is selectively maintained in CD8(+) T cells from secondary lymphoid organs.
    Carramolino L; Zaballos A; Kremer L; Villares R; Martín P; Ardavín C; Martínez-A C; Márquez G
    Blood; 2001 Feb; 97(4):850-7. PubMed ID: 11159507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.